Page 6 - Ancer Prostate News Today

Flotufolastat fluorine-18 (Posluma), a new PSMA-targeted PET radiopharmaceutical, has been approved in the US for use in prostate cancer.

Three physician experts discuss the enormous potential of ChatGPT and share their concerns about the rapidly evolving technology.

The researchers looked at data for 258,477 men who had at least three weight measurements between the ages of 17 and 60 years.

JAK inhibitors were not associated with higher risk of myocardial infarction or stroke and venous thromboembolism, compared with TNF-inhibitor users, in a small study.

A new strategy that would limit screening for prostate cancer to men under 70 who are at risk or symptomatic would reduce the potential harm from overdiagnosis and overtreatment, an international panel recommends.

Cancer death rates showed an overall decline in the past 25 years in the United States, but the data also showed disparities in cancer death rates based on race and ethnicity.

Asthma appears to increase the risk for melanoma as well as lung, blood, kidney, and ovarian cancers, but treatment with an inhaled steroid might reduce that risk.

New US guidelines recommend both transperineal and transrectal approaches, while Europe endorses transperineal biopsies.

Self-administered nitrous oxide was linked to less worry among patients undergoing transrectal procedures, a study found. The same technique is coming for the transperineal approach.

An expert panel recommended restricting the expanded first-line indication to patients whose metastatic castration-resistant prostate tumors have BRCA mutations.